IGC Pharma, Inc.
IGC
$0.3262
$0.01986.46%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.52% | 27.80% | 17.57% | 48.38% | -128.03% |
| Total Depreciation and Amortization | 8.28% | -10.49% | -1.22% | 2.50% | 1.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.80% | -3.48% | -22.84% | -86.62% | 606.72% |
| Change in Net Operating Assets | -113.83% | 203.23% | -96.30% | 3,319.23% | -141.94% |
| Cash from Operations | -32.23% | 43.15% | -233.08% | 66.86% | 1.92% |
| Capital Expenditure | 6.90% | 23.68% | -153.33% | 77.94% | -94.29% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | 100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -48.08% | 44.09% | 70.00% | -4,528.57% | -93.52% |
| Cash from Investing | -60.00% | 50.38% | 59.44% | -429.51% | -184.72% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | -- | 100.00% | 0.00% |
| Issuance of Common Stock | -56.48% | -68.30% | 276.01% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -56.55% | -68.33% | 275.86% | 66,800.00% | -100.03% |
| Foreign Exchange rate Adjustments | 100.00% | -650.00% | 0.00% | 100.00% | 110.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -287.05% | -144.41% | 447.78% | 89.08% | -226.48% |
